Back to results
US 6,686,362 B2Granted
Indolinone derivatives
AssigneeTheravance, Inc.
InventorsJohn H. Griffin, Roger Briesewitz, Jonathan W. Wray
Life of this patent
Estimating the term…
Abstract
Compounds of formula (I) in which R1, R2, R3 and R4 have the meanings given in the specification, are receptor tyrosine kinase inhibitors useful in the treatment of proliferative disorders, such as cancer.
Claims5
A compound of formula (Ia):
- wherein R is hydrogen, methyl, or ethyl;
- or a pharmaceutically-acceptable salt thereof.
Dependencies are inferred from the claim text.